What is the generic name?

EFAVIRENZ, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE

What is the Trade Name for EFAVIRENZ, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE?

Efavirenz, Lamivudine and Tenofovir Disoproxil Fumarate

What are the Indications for EFAVIRENZ, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE?

• 1 INDICATIONS AND USAGE Efavirenz, lamivudine and tenofovir disoproxil fumarate tablets are indicated as a complete regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adult and pediatric patients weighing at least 40 kg. Efavirenz, lamivudine and tenofovir disoproxil fumarate tablets are three-drug combination of efavirenz (EFV), a non-nucleoside reverse transcriptase inhibitor, and lamivudine (3TC) and tenofovir disoproxil fumarate (TDF), both nucleo(t)side reverse transcriptase inhibitors and are indicated as a complete regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adult and pediatric patients weighing at least 40 kg. ( 1 )

References: https://open.fda.gov/